Exploratory study of intravitreal clindamycin and dexamethasone in the treatment of acute toxoplasma chorioretinitis associated vitritis - intravitreal clindamycin and dexamethasone for toxoplasma vitritis
Phase 1
- Conditions
- Vitritis secondary to acute toxoplasma chorioretinitisMedDRA version: 8.1 Level: LLT Classification code 10008770 Term: Chorioretinitis due to toxoplasmosis
- Registration Number
- EUCTR2006-005008-15-GB
- Lead Sponsor
- Moorfields Eye Hospital NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1.primary or secondary toxoplasma chorioretinitis (TCR) with no macular involvement
2.vitritis reducing vision to 6/12 or less
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1.primary or secondary TCR with macular retinitis or lesion within 1 Disc area of disc
2.known steroid responder
3.systemic treatment for TCR already commenced
4.risk of HIV or other immunosuppression from history
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method